LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $766,000 | -25.3% | 240,000 | 0.0% | 99.74% | +0.1% |
| Q1 2022 | $1,025,000 | -8.2% | 240,000 | 0.0% | 99.61% | +0.2% |
| Q4 2021 | $1,116,000 | +16.5% | 240,000 | 0.0% | 99.38% | +0.2% |
| Q3 2021 | $958,000 | -6.7% | 240,000 | 0.0% | 99.17% | +4.3% |
| Q2 2021 | $1,027,000 | +0.9% | 240,000 | 0.0% | 95.09% | +0.3% |
| Q1 2021 | $1,018,000 | +9.3% | 240,000 | 0.0% | 94.79% | +2.2% |
| Q4 2020 | $931,000 | -3.7% | 240,000 | 0.0% | 92.73% | +18.5% |
| Q3 2020 | $967,000 | -5.4% | 240,000 | 0.0% | 78.24% | -1.3% |
| Q2 2020 | $1,022,000 | +1.4% | 240,000 | 0.0% | 79.29% | -1.0% |
| Q1 2020 | $1,008,000 | +6.9% | 240,000 | 0.0% | 80.13% | +617.1% |
| Q4 2019 | $943,000 | -55.4% | 240,000 | 0.0% | 11.17% | -85.1% |
| Q3 2019 | $2,112,000 | -4.9% | 240,000 | 0.0% | 75.03% | -1.1% |
| Q2 2019 | $2,220,000 | +43.9% | 240,000 | 0.0% | 75.87% | +22.7% |
| Q1 2019 | $1,543,000 | – | 240,000 | – | 61.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,440,419 | $102,697,000 | 37.12% |
| RTW INVESTMENTS, LP | 1,028,929 | $30,714,000 | 8.08% |
| Consonance Capital Management LP | 1,420,742 | $42,409,000 | 4.44% |
| Perceptive Advisors | 2,139,274 | $63,857,000 | 3.64% |
| Broadfin Capital, LLC | 782,887 | $23,369,000 | 2.83% |
| Crawford Lake Capital Management, LLC | 171,373 | $5,115,000 | 2.03% |
| Crawford Lake Capital Management, LLC | 162,600 | $4,380,000 | 1.74% |
| ISZO CAPITAL MANAGEMENT LP | 30,967 | $924,000 | 1.61% |
| FT Options LLC | 33,141 | $989,000 | 1.30% |
| Monashee Investment Management LLC | 100,000 | $2,985,000 | 1.20% |